ABVC BIOPHARMA INC (ABVC) Institutional Ownership Changes & 13F Activity
ABVC BIOPHARMA INC (ABVC). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Vanguard Capital Management Llc, Renaissance Technologies LLC, Citadel Advisors Llc, Xtx Topco Ltd, and Panagora Asset Management Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +72,091 | — | 72,091 | $113.90K | Q2 2026 | Sep 02, 2026 |
| Xtx Topco Ltd | Buy | +48,276 | — | 48,276 | $76.28K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +20,059 | — | 20,059 | $31.69K | Q2 2026 | Aug 14, 2026 |
| Vanguard Capital Management Llc | Buy | +183,925 | +96.5% | 374,499 | $591.71K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +32,352 | +1826.8% | 34,123 | $53.91K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +16,556 | +51.6% | 48,643 | $76.86K | Q2 2026 | Aug 13, 2026 |
| Geode Capital Management, Llc | Buy | +6,873 | +3.1% | 228,042 | $360.38K | Q2 2026 | Aug 12, 2026 |
| Panagora Asset Management Inc | Buy | +36,682 | — | 36,682 | $57.96K | Q2 2026 | Aug 06, 2026 |
| Caitong International Asset Management Co., Ltd | Buy | +6 | — | 6 | $9.00 | Q2 2026 | Aug 05, 2026 |
| Citigroup Inc | Buy | +540 | — | 540 | $853.00 | Q2 2026 | Aug 03, 2026 |
| Lifesteps Financial, Inc. | Buy | +300 | — | 300 | $474.00 | Q2 2026 | Jul 17, 2026 |
| Two Sigma Securities, Llc | Sell | -21,023 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Squarepoint Ops Llc | Sell | -10,547 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -5,423 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Renaissance Technologies LLC | Sell | -95,100 | -100.0% | 0 | $0.00 | Q2 2026 | May 14, 2026 |
| Dimensional Fund Advisors Lp | Sell | -12,227 | -100.0% | 0 | $0.00 | Q2 2026 | May 07, 2026 |
Frequently asked questions about ABVC activity
Which institutional owners are buying ABVC?
Institutional owners buying ABVC include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ABVC activity?
"Buy" means an investor increased their reported position in ABVC compared to the prior reporting period. This reflects growing exposure to ABVC BIOPHARMA INC (ABVC) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ABVC increasing?
Institutional interest in ABVC can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ABVC Institutional Insights
- ABVC Overview
- ABVC 13F Institutional Holders
- ABVC Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ABVC Insider Trading & SEC Form 4 Activity
- ABVC Articles
- Top Institutional Investor Stock Rankings